Search

Your search keyword '"Antimetabolites administration & dosage"' showing total 572 results

Search Constraints

Start Over You searched for: Descriptor "Antimetabolites administration & dosage" Remove constraint Descriptor: "Antimetabolites administration & dosage"
572 results on '"Antimetabolites administration & dosage"'

Search Results

501. Cutaneous uses of the antiproliferative drugs.

502. Advances in Psoriasis.

503. [Antitumor chemotherapy. Trial and results of a new antineoplastic agent with a double mechanism of alkylating and antimetabolic action].

504. Influence of inhibitors of protein synthesis on restitution of tubular transport capacity after unilateral nephrectomy.

507. Phase I and pharmacological study of acivicin by 24-hour continuous infusion.

508. Disposition of 2-mercaptobenzimidazole in rats dosed orally or intravenously.

509. Effect of systemic glutathione depletion by buthionine sulfoximine on sensitivity of murine bladder cancer to cytotoxic agents.

510. Convulsive seizure induced by intracerebral injection of semicarbazide (an anti-vitamin B6) in the mouse.

511. Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver.

512. Chemotherapy of malignant renal tumors.

513. [Chemotherapy of malignant blood diseases].

514. Antitumor drug toxicity: implications for response and for survival.

516. Muscle creatine: in vivo depletion by feeding beta-guanidinopropionic acid.

517. Immunosuppressive agents: generation and consequences of differing dose-response curves.

518. Topical antimetabolites.

519. An introduction to immunosuppressants.

521. [Radiosensitizers for brain tumors--study of radiotherapy].

522. Effect of pyridinol-carbamate on experimental cerebral hemorrhage. II.

523. Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia.

527. [Immunosuppressive therapy in rheumatology (comprehensive review)].

528. Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves of antimetabolites and those for radiation and alkylating agents.

529. Palliation chemotherapy of pelvic carcinoma by systemic, perfusion, and infusion modalities.

530. The role of chemotherapy in the treatment of carcinoma of the oral cavity.

532. The pharmacology of immunosuppressive agents.

533. Synchronization of tumor cell proliferation and the timing of cytostatic drugs.

534. Regional infusion chemotherapy for prolongation of kidney allografts.

535. [Antimetabolites].

536. Systematic search for a systemic hydatid scolicide. I. In vitro screening of chemicals against the scolices of hydatid cysts (Echinococcus granulosus).

537. [Drug therapy of progressive chronic polyarthritis].

538. [Spontaneous and induced resorptions in the mouse].

539. [Use of radiation sensitizing agents in radiotherapy].

540. [Intra-arterial chemotherapy in the treatment of genital carcinomas].

541. Five-year follow-up of "total therapy" of childhood lymphocytic leukemia.

543. Hepatic arterial patency and complications after catheterization for infusion chemotherapy.

544. [Carcinogenesis and immunosuppression].

545. Mutagenicity trials under toxicological aspects.

546. [Topical intra-arterial infusion of antineoplastic agents].

547. Combination chemotherapy in generalized Hodgkin's disease.

548. Effects of pyrithiamin injection into the brain of rats.

549. Effect of neomycin on exchangeable pools of cholesterol in the steady state.

550. The aetiology of cerebrocortical necrosis: the effects of administering antimetabolites of thiamine to preruminant calves.

Catalog

Books, media, physical & digital resources